FSHD News's Avatar

FSHD News

@fshd.bsky.social

Ex: FSHD News on Twitter - @mpcfshd FSHD NEWS over the world. Research and patients networks #FSHD #FacioScapuloHumeral #CureFSHD #WorldFSHDDay = June 20th

57 Followers  |  18 Following  |  38 Posts  |  Joined: 15.11.2024  |  1.5814

Latest posts by fshd.bsky.social on Bluesky

๐Ÿ‡ง๐Ÿ‡ช ๐Ÿ‡จ๐Ÿ‡ฑ ๐Ÿ‡ฌ๐Ÿ‡ง

๐Ÿ‘‰DUX4 at 25: how it emerged from "junk DNA" to become the cause of #FSHD

๐Ÿ’กThe history of DUX4, fromgenetic linkage studies in the early 1990s, through to identificationof the DUX4 gene in 1999

๐Ÿ“ฐhttps://pubmed.ncbi.nlm.nih.gov/40855454/

Alexandra Belayew , Alberto L Rosa & Peter S Zammit

28.08.2025 15:12 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
JCI - Iron supplementation alleviates pathologies in a mouse model of facioscapulohumeral muscular dystrophy

๐Ÿ‡ฏ๐Ÿ‡ต
๐Ÿ‘‰Iron supplementation alleviates pathologies in a mouse model of #FSHD

๐Ÿ’กDUX4-provoked toxicity is involved in the activation of the ferroptosis-related pathway

๐Ÿ“ฐhttps://jci.org/articles/view/181881
(pdf) jci.org/articles/vie...

12.07.2025 11:25 โ€” ๐Ÿ‘ 0    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on FSHD (Facioscapulohumeral Muscular Dystrophy)... /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell...

๐Ÿงฌ
@Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on #FSHD using universal #iPS cells

www.prnewswire.com/news-release...

11.07.2025 17:21 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡ช๐Ÿ‡บrope
๐Ÿ‘‰Machine learning-driven Heckmatt grading in #FSHD: A novel pathway for musculoskeletal ultrasound analysis

๐Ÿ’กAutomatic pipeline for muscle ultrasound analysis, leveraging machine for segmentation, classification, and quantitative Heckmatt grading

๐Ÿ“ฐhttps://pubmed.ncbi.nlm.nih.gov/40020544/

25.04.2025 14:40 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡บ๐Ÿ‡ธ ๐Ÿ‡ช๐Ÿ‡บ
๐Ÿ‘‰Strength and functional correlates of reachable workspace in #FSHD

Correlations between total relative surface area and upper extremity strength measured by quantitative muscle testing

pubmed.ncbi.nlm.nih.gov/39978161/

22.04.2025 15:37 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡ณ๐Ÿ‡ฑ
๐Ÿ‘‰Prevalence and incidence rates of 17 neuromuscular disorders: An updated review of the literature

๐Ÿ’ก#FSHD:
#Incidence rate 0.3
#Prevalence rate-Mean /100,000: 5
Prevalence rate-Range/100,000: 0.79โ€“12

๐Ÿ“ฐhttps://journals.sagepub.com/doi/abs/10.1177/22143602241313118

30.03.2025 10:50 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‘‰ Proteomic profiling uncovers sexual dimorphism in the muscle response to wheel running exercise in the FLExDUX4 murine model of #FSHD

๐Ÿ’กmice recapitulates characteristics of FSHD, ; alterations to mitochondria, RNA metabolism, oxidative stress, and apoptosis.

๐Ÿ“ฐ www.biorxiv.org/content/10.1...

22.03.2025 18:12 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡ฆ๐Ÿ‡บ
๐Ÿ‘‰Sarcolemmal dysfunction in #FSHD: An assessment using muscle velocity recovery cycles

๐Ÿ’กThe study suggests that functional changes in muscle membrane properties occur early in FSHD

๐Ÿ“‘https://pubmed.ncbi.nlm.nih.gov/40085998/

16.03.2025 12:10 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Muscle imaging in facioscapulohumeral muscular dystrophy research: A scoping review and expert recommendations Facioscapulohumeral muscular dystrophy (FSHD) is a hereditary muscle disorder and the second most common muscular dystrophy in adulthood, with an estimated prevalence of approximately 12 per 100,000 i...

๐Ÿ‡ช๐Ÿ‡บ๐Ÿ‡บ๐Ÿ‡ธ
๐Ÿ‘‰Muscle imaging in #FSHD research: A scoping review and expert recommendations

๐Ÿ’กA specific muscle ultrasound protocol is suitable for diagnosis and has potential as both a prognostic and monitoring biomarker in FSHD research.

๐Ÿ“‘ www.nmd-journal.com/article/S096...

14.03.2025 14:07 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡ช๐Ÿ‡บ๐Ÿ‡ซ๐Ÿ‡ท๐Ÿ‡ฎ๐Ÿ‡น
๐Ÿ‘‰High prevalence of #FSHD and inflammatory myopathies association: Is there an interplay ?

๐Ÿ’กPrevalence of FSHD in the IIM cohort was 1/350, and the prevalence of IIM in the FSHD cohort was 1/40

๐Ÿ“ฐhttps://pubmed.ncbi.nlm.nih.gov/39855012/

12.03.2025 17:43 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡ช๐Ÿ‡บ
๐Ÿ‘‰Increased muscle satellite cell content and preserved telomere length in response to combined exercise training in patients with #FSHD

๐Ÿ’กThese findings suggest that such training supports muscle regeneration without accelerating cellular aging.

t.co/yLMeTn0rsy

05.03.2025 11:30 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡จ๐Ÿ‡ฑ
๐Ÿ‘‰The Unexplored Role of Connexin Hemichannels in Promoting #FSHD Progression

๐Ÿ’กFSHD progression, with a focus on hormones, inflammation, reactive oxygen species (ROS), and mitochondrial function

pmc.ncbi.nlm.nih.gov/articles/PMC...

28.02.2025 16:50 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
https://pmc.ncbi.nlm.nih.gov/articles/PMC11817091/

๐Ÿ‡จ๐Ÿ‡ณ
๐Ÿ‘‰The distribution of #D4Z4 repeats in #China and direct prenatal diagnosis of #FSHD by optical genome mapping

๐Ÿ’กOptical genome mapping is an accurate and effective method for the prenatal diagnosis

t.co/1mpXs68lxp

18.02.2025 15:32 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡ช๐Ÿ‡บ ๐Ÿ‡ฆ๐Ÿ‡น
๐Ÿ‘‰Bilateral foot drop as presenting feature of #FSHD 1

๐Ÿ’กThe relevance of a thorough clinical examination, accompanied by conventional diagnostic applications to obtain a correct #genetic #diagnosis

๐Ÿ“ฐhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11722158/

09.02.2025 11:09 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
https://pmc.ncbi.nlm.nih.gov/articles/PMC11708601/

๐Ÿ‡บ๐Ÿ‡ธ
๐Ÿ‘‰Sternal Reconstruction for Refractory Pectus Excavatum From #FSHD

๐Ÿ’กSuccessful implantation of a customized sternal plate in the treatment of a patient with refractory pectus excavatum

t.co/rvqXQzECCh

27.01.2025 13:16 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

๐Ÿ‘‰Double trouble: a comprehensive study into unrelated genetic comorbidities in adult patients with #FSHD

๐Ÿ’กIn 14/18 patients, we identified FSHD-unrelated genetic causes, most often unrelated repeat expansion disorders.

๐Ÿ“ฐhttps://pubmed.ncbi.nlm.nih.gov/39775061/

26.01.2025 16:58 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
DUX4-induced HSATII RNA accumulation drives protein aggregation impacting RNA processing pathways RNA-driven protein aggregation leads to cellular dysregulation by sequestering regulatory proteins, disrupting normal cellular processes, and contributing to the development of diseases and tumorigene...

๐Ÿ‡บ๐Ÿ‡ธ
๐Ÿ‘‰#DUX4-induced HSATII RNA accumulation drives protein aggregation impacting RNA processing pathways

๐Ÿ’กHSATII-RNP formation on #RNA processing pathways provides valuable insight underlying #FSHD.

pmc.ncbi.nlm.nih.gov/articles/PMC...

23.01.2025 15:12 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Analysis of Body Fluid Distribution, Phase Angle and Its Association With Maximal Oxygen Consumption in Facioscapulohumeral Dystrophy: An Observational Study Background and Aims Body composition parameters associated with aerobic fitness, mirrored by maximal oxygen consumption (Vฬ‡O2max), have recently gained interest as indicators of physical efficiency ...

Analysis of Body Fluid Distribution, Phase Angle and Its Association With Maximal Oxygen Consumption in #FSHD: An Observational Study

The phase angle of FSHD patients is lower than healthy controls.

onlinelibrary.wiley.com/doi/10.1002/...

22.01.2025 10:57 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
SMCHD1 genetic variants in type 2 facioscapulohumeral dystrophy and challenges in predicting pathogenicity and disease penetrance - European Journal of Human Genetics European Journal of Human Genetics - SMCHD1 genetic variants in type 2 facioscapulohumeral dystrophy and challenges in predicting pathogenicity and disease penetrance

๐Ÿ‡ช๐Ÿ‡บ ๐Ÿ‡ซ๐Ÿ‡ท
๐Ÿ‘‰SMCHD1 genetic variants in type 2 #FSHD & challenges in predicting pathogenicity & disease penetrance

๐Ÿ’กThe intriguing relationship between D4Z4 methylation, SMCHD1 variants with SMCHD1 protein structure-function in FSHD

www.nature.com/articles/s41...

30.12.2024 12:32 โ€” ๐Ÿ‘ 2    ๐Ÿ” 2    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0


๐Ÿ‘‰Age at onset mediates genetic impact on disease severity in #FSHD

๐Ÿ’กIndependent contributions from D4Z4 repeat units, D4Z4 methylation levels, mosaic mutation and inheritance pattern on age at onset variation

๐Ÿ“ฐ pubmed.ncbi.nlm.nih.gov/39711249/

29.12.2024 13:15 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0


๐Ÿ‘‰Longitudinal Insights Into Childhood Onset #FSHD: A 5-Year Natural History Study

๐Ÿ’กThis study contributes to improved counseling for children and their parents

๐Ÿ“ฐhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11655134/

21.12.2024 16:52 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡บ๐Ÿ‡ธ
๐Ÿ‘‰Identifica0tion of disease-specific extracellular vesicle-associated plasma protein biomarkers for Duchenne MD &#FSHD

๐Ÿ’กCirculating extracellular vesicle content disease-specific protein biomarkers for DBMD & FSHD

๐Ÿ“ฐ pubmed.ncbi.nlm.nih.gov/39649602/

10.12.2024 16:42 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
SOLVE FSHD Challenges Innovators with USD$10 Million Bonus Prize to Accelerate FSHD Breakthroughs in XPRIZE Healthspan Competition XPRIZE Healthspan competition announced by SOLVE FSHD invites innovators with USD$10 million bonus prize.

VANCOUVER
๐Ÿ‘‰SOLVE FSHD, a venture philanthropy organization dedicated to accelerate new therapies, is calling on innovators worldwide to compete for the USD$10 million #FSHD Bonus Prize

๐Ÿ“ฐ www.businesswire.com/news/home/20...

06.12.2024 17:13 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1

๐Ÿ‘‰SIX transcription factors are necessary for the activation of DUX4 expression in #fshd

๐Ÿ’กInvolvement of SIX transcription factors in the promotion of #DUX4 expression epigenetic derepression of the #D4Z4 repeats.

๐Ÿ“ฐhttps://skeletalmusclejournal.biomedcentral.com/articles/10.1186/s13395-024-00361-3

06.12.2024 10:52 โ€” ๐Ÿ‘ 4    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡จ๐Ÿ‡ณ
๐Ÿ‘‰Optical genome mapping reveals maternal mosaicism in two Sibling cases of Early-Onset #FSHD

๐Ÿ’กConfirmation of #D4Z4 repeat reduction, particularly in cases involving parental #mosaicism

๐Ÿ“ฐhttps://www.sciencedirect.com/science/article/abs/pii/S0009898124023155?via%3Dihub

03.12.2024 13:54 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Muscle Proteome Analysis of Facioscapulohumeral Dystrophy Patients Reveals a Metabolic Rewiring Promoting Oxidative/Reductive Stress Contributing to the Loss of Muscle Function Facioscapulohumeral muscular dystrophy (FSHD) is caused by the epigenetic de-repression of the double homeobox 4 (DUX4) gene, leading to asymmetric muscle weakness and atrophy that begins in the facia...

๐Ÿ‡ช๐Ÿ‡บ ๐Ÿ‡ฎ๐Ÿ‡น

๐Ÿ‘‰Muscle Proteome Analysis of #FSHD Patients Reveals a Metabolic Rewiring Promoting Oxidative/Reductive Stress Contributing to the Loss of Muscle Function

๐Ÿ’กMolecules identified may represent potential diagnostic & therapeutic targets

www.mdpi.com/2076-3921/13...

30.11.2024 17:08 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡บ๐Ÿ‡ธ

๐Ÿ‘‰Respiratory function & evaluation in individuals with #FSHD in the Muscular Dystrophy Surveillance, Tracking and Research Network

๐Ÿ’ก#Respiratory evaluation at #diagnosis could identify insufficiency as a complication

๐Ÿ“ฐhttps://pubmed.ncbi.nlm.nih.gov/39579597/

28.11.2024 16:59 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Management of FSHD symptoms: current assistive technologies and pharmacological approaches Facioscapulohumeral Muscular Dystrophy (FSHD) is a genetically linked disorder characterized by the progressive deterioration of muscles controlling facial and scapular movement. The severity and d...

๐Ÿ‡บ๐Ÿ‡ธ
๐Ÿ‘‰Management of #FSHD symptoms: current assistive technologies and pharmacological approaches

๐Ÿ’กDespite advances in #pharmacological #research the variability necessitates a personalized approach

๐Ÿ“ฐ www.tandfonline.com/doi/full/10....

27.11.2024 09:47 โ€” ๐Ÿ‘ 1    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

๐Ÿ‡ช๐Ÿ‡บ ๐Ÿ‡ณ๐Ÿ‡ฑ
๐Ÿ‘‰Three-dimensional tissue engineered skeletal muscle modelling #FSHD

๐Ÿ’ก3D skeletal muscle model can be employed for preclinical research and In the future be used for preclinical drug screening.

๐Ÿ“ฐhttps://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae379/60742616/awae379.pdf

26.11.2024 11:48 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
https://www.genengnews.com/topics/drug-discovery/novartis-buys-kate-therapeutics-expanding-in-neuro-gene-therapy/

๐Ÿšจ Novartis has acquired Kate Therapeutics for up to $1.1 billion

๐Ÿ‘‰Kateโ€™s FSHD program is designed to deliver a microRNA against DUX4 potently and uniformly to skeletal muscles throughout the body, knocking down DUX4 in skeletal muscles.

๐Ÿ“ฐ t.co/ExvJrtekAA

23.11.2024 14:38 โ€” ๐Ÿ‘ 3    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

@fshd is following 18 prominent accounts